ALLITESPLUS PHARMACY PRIVATE LIMITED

About GSTIN 33AAYCA0126G1ZU

ALLITESPLUS PHARMACY PRIVATE LIMITED is a Private Limited Company registered under GST in Tamil Nadu with GSTIN 33AAYCA0126G1ZU. The GST registration was obtained on 24 December 2022. The current status of this GST registration is .

The PAN associated with this GSTIN is AAYCA0126G. The registration type is Regular. The primary nature of business activities is Office / Sale Office, Retail Business. This GST registration is linked to ALLITESPLUS PHARMACY PRIVATE LIMITED (CIN: U52520TN2022PTC157169).

GST Registration Details

GSTIN
33AAYCA0126G1ZU
PAN Number
Legal Name
ALLITESPLUS PHARMACY PRIVATE LIMITED
Trade Name
Not Available
Status
GST Type
Regular
State / Jurisdiction
Tamil Nadu (Code: 33)
Entity Type
Private Limited Company
Nature of Business
Office / Sale Office, Retail Business
Registration Date
24 Dec 2022
Principal Place of Business
P.No.122A, D.No.90 CLC Works Road Chennai Tamil Nadu

Linked Company Information

CIN
U52520TN2022PTC157169
Company Class
Private
Company Status
Active

Frequently Asked Questions

Is 33AAYCA0126G1ZU a valid GST number?

Yes, 33AAYCA0126G1ZU is a valid GSTIN registered under the Goods and Services Tax (GST) system in India. It belongs to ALLITESPLUS PHARMACY PRIVATE LIMITED in Tamil Nadu. The current status of this registration is .

What is the legal name registered under 33AAYCA0126G1ZU?

The legal name registered under GSTIN 33AAYCA0126G1ZU is ALLITESPLUS PHARMACY PRIVATE LIMITED.

What is the PAN linked to 33AAYCA0126G1ZU?

The PAN (Permanent Account Number) linked to GSTIN 33AAYCA0126G1ZU is AAYCA0126G. The first two digits of a GSTIN represent the state code (33 for Tamil Nadu), followed by the 10-character PAN, an entity code, the letter 'Z', and a check digit.

Which company is 33AAYCA0126G1ZU linked to?

GSTIN 33AAYCA0126G1ZU is linked to ALLITESPLUS PHARMACY PRIVATE LIMITED (CIN: U52520TN2022PTC157169), a Private company registered in India.

Data last updated: 15 Feb 2026, 06:28 | Record updated: 15 Feb 2026